Neogenomics Inc (NEO) SEC Filing 8-K Material Event for the period ending Tuesday, October 23, 2018

Neogenomics Inc

CIK: 1397533 Ticker: NEO

View differences made from one to another to evaluate Neogenomics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Neogenomics Inc.


Assess how Neogenomics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Neogenomics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Neogenomics Inc provided additional information to their SEC Filing as exhibits

Ticker: NEO
CIK: 1077183
Form Type: 8-K Corporate News
Accession Number: 0001077183-18-000099
Submitted to the SEC: Fri Oct 26 2018 5:23:38 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Tuesday, October 23, 2018
Industry: Testing Laboratories
  1. Financial Exhibit
  2. New Agreement
  3. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: